# Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/aliskiren-and-perindopril-reduce-the-levels-of-transforming-growth-factor-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sławomir Lizakowski,Leszek Tylicki,Marcin Renke,Przemysław Rutkowski,Zbigniew Heleniak,Maja Sławińska-Morawska,Ewa Aleksandrowicz‐Wrona,Sylwia Małgorzewicz,Bolesław Rutkowski |
| Citations | 22 |
| DOI | 10.1038/ajh.2012.14 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/ajh/article-pdf/25/6/636/8580513/25_6_636.pdf |
| OpenAlex ID | https://openalex.org/W2319486435 |
| PMID | 22357413 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Zbigniew Heleniak](https://scholariq.org/researchers/zbigniew-heleniak/)

## Paper primary topic

- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)

## Paper topics

- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.